|
|
||||||||
1 Department of Physiology, McGill University, Montreal, Quebec, Canada H3G 1Y6; and 2 Division of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
| |
ABSTRACT |
|---|
|
|
|---|
The
Na+/H+
exchanger NHE1 isoform is an integral component of cardiac
intracellular pH homeostasis that is critically important for
myocardial contractility. To gain further insight into its physiological significance, we determined its cellular distribution in
adult rat heart by using immunohistochemistry and confocal microscopy.
NHE1 was localized predominantly at the intercalated disk regions in
close proximity to the gap junction protein connexin 43 of atrial and
ventricular muscle cells. Significant labeling of NHE1 was also
observed along the transverse tubular systems, but not the lateral
sarcolemmal membranes, of both cell types. In contrast, the
Na+-K+-ATPase
1-subunit was readily labeled
by a specific mouse monoclonal antibody (McK1) along the entire
ventricular sarcolemma and intercalated disks and, to a lesser extent,
in the transverse tubules. These results indicate that NHE1 has a
distinct distribution in heart and may fulfill specialized roles by
selectively regulating the pH microenvironment of pH-sensitive proteins
at the intercalated disks (e.g., connexin 43) and near the cytosolic
surface of sarcoplasmic reticulum cisternae (e.g., ryanodine receptor),
thereby influencing impulse conduction and excitation-contraction coupling.
ion transporters; pH regulation; subcellular; confocal microscopy
| |
INTRODUCTION |
|---|
|
|
|---|
THE CONTINUOUS contractile activity of the myocardium generates metabolic acid, which must be extruded to maintain cardiac function. This is exemplified by experimentally induced decreases in intracellular pH (pHi), which result in marked reductions in myocardial contractility (41). The precise mechanism of this inotropic effect is not well defined but is associated with reduced myosin-ATPase activity (26), decreased ionic current through voltage-activated Na+ and Ca2+ channels (21, 51, 68), diminished binding of Ca2+ to troponin C of the contractile apparatus (4), and reductions in gap junction conductance (55). Hence, regulation of pHi is of critical importance for normal myocardial function.
At least three different ion transporters contribute to myocardial
pHi regulation: the
Cl
/HCO
3
exchanger (32, 60), the
Na+-HCO
3
cotransporter (30), and the
Na+/H+
exchanger (NHE) (31). Of these, NHE is the main mechanism responsible for returning myocardial pHi to
the neutral range (pHi
7.1-7.3) after an acid load (62). In mammals, at least six NHE
isoforms (NHE1 to NHE6) are known to exist, and they exhibit distinct
differences in their primary structures (~20-60% amino acid
identity), patterns of tissue expression, membrane localization,
functional properties, and physiological roles (reviewed in Refs. 43
and 61). Cardiac tissue from rats (44, 67), rabbits (58), and humans
(15) expresses predominantly the NHE1 mRNA; hence, it is the main NHE isoform responsible for controlling myocardial
pHi. The heart also expresses
NHE6, but it is localized to the mitochondria inner membrane (40),
where it contributes primarily to matrix cation (Na+ and indirectly
Ca2+) homeostasis (7).
Aside from its role in normal myocardial pHi regulation, accumulating evidence points to NHE1 as a contributing factor in the pathophysiology of cardiac ischemia and reperfusion injuries. Metabolic alterations that create large pH gradients across the sarcolemma lead to hyperactivation of NHE1 during the early stages after ischemia and reperfusion, causing a dramatic influx of Na+ that secondarily elevates intracellular Ca2+ (8, 14, 24, 47, 52). This disturbance in Ca2+ homeostasis is generally believed to contribute to cardiac arrhythmias, necrosis, and, eventually, contractile failure. The role of NHE1 in ischemic and reperfusion injuries, however, is most convincingly demonstrated by animal studies showing that treatment with amiloride, a relatively nonspecific inhibitor of NHE1, significantly reduces Na+ and Ca2+ overload and thus has cardioprotective properties (23). Similar protective effects are obtained with amiloride analogs (9, 22, 25, 36, 39, 46, 57) and new benzoyl guanidinium compounds [e.g., HOE-694 (19, 38, 54, 66) and HOE-642 (cariporide) (53, 65)], which are more potent and selective antagonists of NHE1. The antiarrhythmic action of amiloride has also been demonstrated in human clinical studies, in which it suppressed inducible ventricular tachycardia (10) and spontaneous ventricular premature beats (37). These studies highlight the importance of examining the molecular and cellular properties of NHE1 to further understand its physiological importance in myocardial function.
NHE1 activity has been demonstrated in isolated sarcolemmal vesicles (48), although its precise location in cardiac tissue is unknown. Recent immunolocalization and subcellular fractionation studies in other cell types have provided initial indications that NHE1 is not distributed homogeneously throughout the plasma membrane. For example, although present throughout the surface membrane of adherent fibroblasts, NHE1 preferentially accumulates along the border of lamellipodia in close association with vinculin, talin, and F-actin, suggesting that it can be localized to specialized regions by interacting with the cytoskeleton (18). Likewise, NHE1 is restricted to the basolateral surface of polarized epithelial cells (3, 59). In this study, we examined the hypothesis that NHE1 is localized to discrete regions of the myocardial membrane. An NHE1 isoform-specific polyclonal antibody was used in conjunction with confocal immunofluorescence. The data show that NHE1 is selectively targeted to the intercalated disks and transverse tubules, suggesting that it may fulfill specialized physiological roles at these sites.
| |
METHODS |
|---|
|
|
|---|
Rat myocardial isolation.
Adult Sprague-Dawley rats (250-350 g) were anesthetized with
CO2. A midline thoracotomy was
performed, and the heart was rapidly removed. The preparation,
containing the entire heart, was placed in a tissue bath superfused
with Tyrode solution (in mmol/l: 121 NaCl, 5 KCl, 15 NaHCO3, 1 Na2HPO4,
2.8 Na-acetate, 1 MgCl2, 2.2 CaCl2, and 5.5 glucose) and gassed
with a 95% O2-5%
CO2 mixture. Temperature was
maintained at 37.0°C, and the pH was 7.4. The preparation was
pinned down in its proper orientation and then frozen in isopentane
that had been previously cooled to
40°C. The frozen
preparation was then trimmed into small blocks containing the various
regions under investigation. The blocks were mounted on a cryostat
tissue holder using Histo Prep (Fisher Scientific), placed on the
rapid-freeze stage of a Microm cryostat (Carl Zeiss), and cut into
20-µm-thick sections.
Cell culture.
AP-1 cells are
Na+/H+
exchange-deficient Chinese hamster ovary cells that were created by
random chemical mutagenesis and selected by the proton-suicide
technique (50). AP-1NHE1 cells
were obtained by stable transfection of AP-1 cells with the complete
coding region of the rat NHE1 isoform, as described in detail elsewhere
(42). The AP-1 cells were maintained in complete
-minimal essential
medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin,
100 µg/ml streptomycin, and 25 mmol/l
NaHCO3 (pH 7.4) and incubated in a
humidified atmosphere of 95% air-5%
CO2 at 37°C.
Primary antibodies.
Isoform-specific polyclonal antibodies to NHE1 were raised by injecting
rabbits with a fusion protein constructed with
-galactosidase of
Escherichia coli and the last 157 amino acids of the hydrophilic (COOH-terminal) domain of the human
exchanger and then affinity purified as described (18). Gap junctions
were identified using a monoclonal antibody directed against residues
252-270 of the COOH terminus of the rat connexin 43 molecule
(Chemicon International). The
Na+-K+-ATPase
was identified with the use of a mouse monoclonal antibody (McK1)
directed against the amino acids DKKSKK near the
NH2 terminus of the rat
Na+-K+-ATPase
1-subunit (generously provided
by Dr. Kathy Sweadner, Massachusetts General Hospital, Boston, MA)
(56).
Membrane preparations.
Adult Sprague-Dawley rats were anesthetized with
CO2 and killed by cervical
dislocation, and the chest cavity was opened. The heart was transected
below the major vessels, rinsed in PBS at 4°C, and frozen at
70°C. Rat heart membranes were prepared according to the
method of Hosey et al. (20) with minor modifications. All procedures
were performed at 4°C, and all solutions contained the Complete
protease inhibitor cocktail (Boehringer Mannheim, Mannheim, Germany).
Hearts were minced, diluted in 10 volumes of Tris-EDTA (TE) buffer (10 mmol/l Tris and 1 mmol/l EDTA, pH 7.4), and homogenized three times (10 s each) with a Brinkman Polytron (Brinkman Instruments, Westbury, NY)
at a setting of 9. Nuclei and cell debris were pelleted by
centrifugation at 1,000 g for 10 min.
The pellet was rehomogenized in TE buffer and the centrifugation step
repeated. The supernatants from both low-speed spins were pooled and
centrifuged at 30,000 g for 30 min. To
depolymerize the actin, the pellet was resuspended in TE containing 0.6 mol/l KI and incubated on ice for 30 min. After centrifugation at
30,000 g for 30 min, the resulting
pellet was resuspended in TE and washed two times to completely remove
the KI. The final pellet was solubilized by boiling in TE containing
1% SDS, and the insoluble material was centrifuged at 13,000 g for 30 min.
70°C until use.
SDS-PAGE and immunoblotting. Samples containing AP-1 (20 µg protein) and rat heart (40 µg protein) membranes were resolved on 10% SDS-polyacrylamide gels and electrophoretically transferred to PolyScreen polyvinylidene difluoride (PVDF) membranes (NEN, Boston, MA). After transfer, the PVDF membranes were quenched in PBS containing 5% nonfat dry milk and 0.1% wt/vol Tween 20 for 1 h. Polyclonal NHE1 antiserum was added to a final dilution of 1:5,000, and the incubation was allowed to proceed for another 2 h at room temperature. The membranes were further incubated with goat anti-rabbit IgG conjugated with horseradish peroxidase (New England BioLabs) for 1 h at room temperature, and the labeled proteins were detected by enhanced chemiluminescence using a Western blotting detection kit (Amersham).
To demonstrate the specificity of the immunoreactivity, duplicate samples were submitted to the same protocol except that the primary antibody was preincubated for 1 h with the NHE1 fusion protein (1 µg/ml final concentration) used to generate the antiserum.Immunohistochemistry. Cryostat sections (20 µm thick) prepared from frozen hearts were mounted onto slides and air-dried at room temperature for 1 h. After the sections were permeabilized and blocked with 0.2% Triton X-100-0.5% BSA in PBS, they were incubated for 2 h at room temperature with primary antibody diluted in 0.2% Triton X-100-0.5% BSA in PBS. After being washed three times in PBS (pH 7.2), the sections were incubated with secondary antibody (Texas Red-conjugated goat anti-rabbit IgG or FITC-conjugated goat anti-mouse IgG, Jackson Immunoresearch Laboratories) diluted in 0.2% Triton X-100-0.5% BSA in PBS for 1 h at room temperature and then rinsed three times in PBS. Sections were then mounted using Immuno Flore (ICN). Controls include omission of the primary antibodies directed against NHE1, connexin 43, and Na+-K+-ATPase and NHE1 antibody competition with the fusion protein that the antibody was generated against.
Immunocytochemistry. Cells grown on coverslips were fixed in 1% paraformaldehyde for 15 min at room temperature and then rinsed three times in PBS (pH 7.2). Cells were then permeabilized and blocked by incubation in 0.2% Triton X-100-0.5% BSA in PBS for 30 min at room temperature. Cells were subsequently rinsed in PBS and incubated with appropriately diluted primary antibody in 0.2% Triton X-100-0.5%BSA in PBS for 1 h at room temperature. After being rinsed three times in PBS, cells were incubated in secondary antibody (Texas Red-conjugated goat anti-rabbit IgG, Jackson Immunoresearch Laboratories) diluted in 0.2% Triton X-100-0.5%BSA in PBS for 1 h at room temperature and then rinsed three times in PBS. Sections were then mounted using Immuno Flore (ICN).
Confocal laser scanning microscopy. For confocal microscopy, sections from nine hearts were analyzed for immunolocalization of NHE1. An additional four hearts were analyzed for localization of Na+-K+-ATPase and colocalization of NHE1 and connexin 43. All imaging was performed using a Zeiss LSM 410 inverted confocal microscope. Texas Red-conjugated secondary antibodies were excited with a helium/neon (543 nm) laser and were imaged on a photomultiplier after passage through FT560 and LP590 filter sets. FITC-conjugated secondary antibodies were imaged by exciting the sample with a 488-nm line from an argon/krypton laser, and the resulting fluorescence was collected on a photomultiplier after passage through FT510 and BP515-540 filter sets. All images were printed on a Kodak XLS8300 high-resolution (300 dpi) printer. Optical sections were taken using a ×25, 0.8 NA objective (optical thickness 3.1 µm) or a ×63, 1.4 NA objective (optical thickness 1.0 µm). The imaging parameters, including contrast and brightness and acquisition times, were similar for all positive and negative experiments within Figs. 2-7. The data presented in this study are identical to, and representative of, all experiments.
| |
RESULTS |
|---|
|
|
|---|
Myocardial distribution of
Na+/H+
exchangers.
To determine the cellular location of NHE1 in the intact rat
myocardium, we used confocal immunofluorescence microscopy and an
isoform-specific anti-human NHE1 antibody that has been successfully used for the detection of NHE1 by immunocytochemistry and Western blotting (17, 18). Rat NHE1 has a high degree of sequence similarity
with human NHE1 and was therefore anticipated to react with the
anti-human NHE1 antibody. Figure 1 shows
the specificity of the antibody as determined by immunoblotting of
protein extracts from NHE1-transfected fibroblasts and heart tissue; a
prominent immunoreactive band of ~110 kDa (fully glycosylated form)
and smaller amounts of dimerized (~200 kDa) and nonglycosylated
(~90 kDa) forms were observed in crude cell extracts from stably
transfected AP-1 cells overexpressing rat NHE1
(AP-1NHE1, Fig. 1,
lane 1), consistent with previous
reports (12, 17). In comparison, enriched membranes isolated from rat
heart (Fig. 1, lane 2) contained
smaller amounts of the fully glycosylated NHE1 and minor amounts of the
dimerized form, but the nonglycosylated protein was absent or below the
detection sensitivity of the antibody. These bands could be competed
off by incubation of the primary antibody with excess soluble NHE1
fusion protein (Fig. 1, lanes 3 and
4), demonstrating the specificity of
this detection system. Other smaller, fainter bands were also detected
in extracts from AP-1NHE1 cells
and heart tissue. Some of these were competed off by excess soluble
NHE1 fusion protein, suggesting that they may be proteolytic products
of NHE1 that arose during tissue processing. Other bands were neither
consistently observed between different experiments nor effectively
quenched by the soluble NHE1 fusion protein and, hence, are likely of
nonspecific origin. Further analysis showed significant labeling of
NHE1 throughout the cell surface and, to a lesser extent, in the
perinuclear region of transfected
AP-1NHE1 cells (Fig.
2A),
whereas in nontransfected AP-1 cells, surface-associated and
perinuclear immunofluorescence was extremely faint and diffuse (Fig.
2B), in agreement with an earlier
report using whole cells (18). These initial experiments suggested that
the fluorescence pattern generated by this antibody is a valid
indicator of the distribution of NHE1 in cells and tissues.
|
|
|
|
1-subunit, which is distributed
along the surface sarcolemma and transverse tubules (35, 56). As shown
in Fig. 5 at low (Fig. 5,
A and
B) and high (Fig.
5C) magnification, labeling
longitudinal sections of rat ventricular muscle with a mouse monoclonal
antibody directed against rat connexin 43 revealed clusters of
transversely oriented gap junctions at the intercalated disks, in
agreement with other studies (2). Labeling was not detected in control sections treated with the FITC-conjugated secondary antibody alone (Fig. 5D). However, when ventricular
tissue was labeled with a specific monoclonal antibody (McK1) raised
against the rat
Na+-K+-ATPase
1-subunit, it showed a more
uniform distribution along the entire sarcolemma and intercalated disk
region (Fig. 6,
A and
B). Less prominent labeling is
also observed in the transverse tubules at higher magnifications (Fig.
6C). Again, control sections treated
with the secondary antibody alone (Fig.
6D) were negative. These latter
results are consistent with reports of other studies in which the same
anti-Na+-K+-ATPase
1-antibody was used (35, 56).
Dual labeling experiments of NHE1 (Fig.
7A) and
connexin 43 (Fig. 7B)
confirm that they are colocalized to the intercalated disk regions
(Fig. 7C), although they do not
appear to occupy the same sites.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
NHE1 is localized in rat cardiac myocytes at intercalated disks and transverse tubules. Biochemical studies have indicated that Na+/H+ exchanger activity (i.e., NHE1 isoform) is present in isolated sarcolemmal vesicles (48). By using an isoform-specific anti-NHE1 polyclonal antibody and confocal immunofluorescence microscopy, we have shown that NHE1 is preferentially localized at the intercalated disk regions and transverse tubular system of adult rat atrial and ventricular muscle cells. In this study, the specificity of immunolabeling in rat heart is demonstrated by the lack of a detectable signal in the presence of a competing soluble form of the NHE1 antigen added during incubation with the primary antibody and by the absence of a signal in the presence of secondary antibody alone. Taken together, these data strongly suggest that the observed immunolabeling represents localization of NHE1 protein to the intercalated disks and transverse tubules.
Immunolabeling of NHE1 at the intercalated disks appears more intense than that of the transverse tubular system. This could represent selective clustering and higher densities of NHE1 protein per unit area of membrane, analogous to the preferential accumulation of NHE1 along the border of lamellipodia in fibroblasts (18). Alternatively, the intense signals may reflect increased membrane surface area due to the infolding of the sarcolemma at the intercalated disks (45). Unexpectedly, NHE1 was not observed along the lateral sarcolemma. The possibility that this membrane compartment was inaccessible to antibodies under the given experimental conditions was excluded by our ready detection of the Na+-K+-ATPase
1-subunit in the lateral
sarcolemma. Whereas the absence of labeling of NHE1 may reflect a level
of abundance that is below the detection sensitivity of the antibody,
the data are more readily explained by the selective targeting of NHE1
to the intercalated disk and transverse tubular membranes. This
distribution differs somewhat from that of the
Na+/Ca2+
exchanger, which, like the
Na+-K+-ATPase
1-subunit, is present
throughout the sarcolemma, the transverse tubules, and the intercalated
disks of isolated ventricular myocytes from adult guinea pig and rat
hearts (16, 27). Other pH regulatory transporters also appear to
exhibit preferential membrane targeting in heart. An
antibody that recognizes both the AE1 and AE3 isoforms of the
Cl
/HCO
3
exchanger revealed that they accumulated mainly at the lateral
sarcolemma and transverse tubules of isolated adult rat ventricular
myocytes (49), although it was not established whether these isoforms
were differentially targeted to these membrane surfaces. The location
of the other major cardiac pH regulatory protein, the
Na+-HCO
3
cotransporter, is currently unknown. Thus the distribution of the NHE1
isoform in cardiac myocytes appears distinct from that of other known
exchangers and pumps. The mechanisms responsible for this differential
membrane localization are unknown.
Functional implications for subcellular localization of NHE1 in heart. The immunofluorescence data revealed that NHE1 accumulates at the intercalated disks in close proximity to the predominant cardiac gap junction protein connexin 43, which suggests that a functional relationship may exist between the two proteins. It is well known that small changes in pHi within the physiological range regulate gap junction conductance (55, 63). The molecular basis for this phenomenon is not fully understood, but electrophysiological studies have shown that decreasing pHi reduces the open probability of individual cardiac gap junction channels (5). Recent structural studies have implicated His95 (11) and the carboxy tail (33) of connexin 43 as critical components involved in "H+ gating" of the cardiac gap junction. Thus it is reasonable to suggest that neighboring NHEs may play a role in this regulation. Indeed, pretreatment of rat neonatal paired cardiomyocytes with amiloride (1 mmol/l), a nonselective inhibitor of NHE1, enhanced the inhibitory effects of acidic pHi on conductance of gap junctions, presumably by retarding extrusion of protons (13). The caveat to this study is that the effects of amiloride could have been secondary to inhibition of other transporters and channels (29), thus making it difficult to firmly establish a functional link between NHE1 activity and gap junction conductance. Nevertheless, the data are consistent with the hypothesis that the high density of NHE1 in the intercalated disk region serves to regulate the pHi environment of gap junctions, particularly connexin 43, thereby influencing intercellular communication.
Aside from NHE1, other ion transport proteins are also concentrated at the intercalated disk region of cardiac myocytes, such as voltage-gated Na+ channels (H1 subtype) (6), voltage-gated K+ channels (1, 34), and inositol 1,4,5-trisphosphate Ca2+ release channels (i.e., IP3 receptors) (28). Whether these ion channels are similarly influenced by physiologically relevant changes in pHi is unknown. Likewise, it is attractive to speculate that the presence of NHE1 along the transverse tubules is functionally coupled to the rapid release of Ca2+ by the sarcoplasmic reticulum Ca2+ release channel (i.e., ryanodine receptor), which is highly pHi-sensitive (64); a minor cytosolic acidification decreases the rate of Ca2+ release, which is directly involved in triggering the contractile process. In conclusion, the data show that NHE1 is specifically targeted to distinct regions of cardiac myocytes. We speculate that NHE1 may fulfill specialized roles in the heart by selectively regulating the pH microenvironment of pH-sensitive proteins at the intercalated disks (e.g., connexin 43) and near the cytosolic surface of sarcoplasmic reticulum cisternae (e.g., ryanodine receptor), thereby influencing impulse conduction and excitation-contraction coupling.| |
ACKNOWLEDGEMENTS |
|---|
This work was funded by the Medical Research Council of Canada. S. Grinstein is an International Scholar of the Howard Hughes Medical Institute and is cross-appointed to the Department of Biochemistry of the University of Toronto. J. Orlowski is supported by a Scientist Award from the Medical Research Council of Canada.
| |
FOOTNOTES |
|---|
K. Petrecca is supported by a studentship from the Fonds pour la Formation de Chercheurs et l'Aide à la Recherche (FCAR).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: J. Orlowski, Dept. of Physiology, McGill Univ., McIntyre Medical Science Bldg., 3655 Drummond St., Montreal, Quebec, Canada H3G 1Y6.
Received 22 July 1998; accepted in final form 2 October 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Barry, D. M.,
J. S. Trimmer,
J. P. Merlie,
and
J. M. Nerbonne.
Differential expression of voltage-gated K+ channel subunits in adult rat heart. Relation to functional K+ channels?
Circ. Res.
77:
361-369,
1995
2.
Beyer, E. C.,
J. Kistler,
D. L. Paul,
and
D. A. Goodenough.
Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues.
J. Cell Biol.
108:
595-605,
1989
3.
Biemesderfer, D.,
R. F. Reilly,
M. Exner,
P. Igarashi,
and
P. S. Aronson.
Immunocytochemical characterization of Na+-H+ exchanger isoform NHE-1 in rabbit kidney.
Am. J. Physiol.
263 (Renal Fluid Electrolyte Physiol. 32):
F833-F840,
1992
4.
Blanchard, E. M.,
and
R. J. Solaro.
Inhibition of the activation and troponin calcium binding of dog cardiac myofibrils by acidic pH.
Circ. Res.
55:
382-391,
1984
5.
Burt, J. M.,
and
D. C. Spray.
Single channel events and gating behavior of the cardiac gap junction channel.
Proc. Natl. Acad. Sci. USA
85:
3431-3434,
1988
6.
Cohen, S. A.
Immunocytochemical localization of rH1 sodium channel in adult rat heart atria and ventricle. Presence in terminal intercalated disks.
Circulation
94:
3083-3086,
1996
7.
Crompton, M.,
and
I. Heid.
The cycling of calcium, sodium, and protons across the inner membrane of cardiac mitochondria.
Eur. J. Biochem.
91:
599-608,
1978[Medline].
8.
Duff, H. J.
Clinical and in vivo antiarrhythmic potential of sodium-hydrogen exchange inhibitors.
Cardiovasc. Res.
29:
189-193,
1995[Medline].
9.
Duff, H. J.,
C. E. Brown,
E. J. Cragoe, Jr.,
and
M. Rahmberg.
Antiarrhythmic activity of amiloride: mechanisms.
J. Cardiovasc. Pharmacol.
17:
879-888,
1991[Medline].
10.
Duff, H. J.,
L. B. Mitchell,
K. M. Kavanagh,
D. E. Manyari,
A. M. Gillis,
and
D. G. Wyse.
Amiloride: antiarrhythmic and electrophysiological actions in patients with sustained ventricular tachycardia.
Circulation
79:
1257-1263,
1989
11.
Ek, J. F.,
M. Delmar,
R. Perzova,
and
S. M. Taffet.
Role of histidine 95 on the pH gating of the cardiac gap junction protein connexin43.
Circ. Res.
74:
1058-1064,
1994
12.
Fafournoux, P.,
J. Noël,
and
J. Pouysségur.
Evidence that Na+/H+ exchanger isoforms NHE1 and NHE3 exist as stable dimers in membranes with a high degree of specificity for homodimers.
J. Biol. Chem.
269:
2589-2596,
1994
13.
Firek, L.,
and
R. Weingart.
Modification of gap junction conductance by divalent cations and protons in neonatal rat heart cells.
J. Mol. Cell. Cardiol.
27:
1633-1643,
1995[Medline].
14.
Fliegel, L.,
and
J. R. B. Dyck.
Molecular biology of the cardiac sodium/hydrogen exchanger.
Cardiovasc. Res.
29:
155-159,
1995[Medline].
15.
Fliegel, L.,
J. R. B. Dyck,
H. Wang,
C. Fong,
and
R. S. Haworth.
Cloning and analysis of the human myocardial Na+/H+ exchanger.
Mol. Cell. Biochem.
125:
137-143,
1993[Medline].
16.
Frank, J. S.,
G. Mottino,
D. Reid,
R. S. Molday,
and
K. D. Philipson.
Distribution of the Na+-Ca2+ exchange protein in mammalian cardiac myocytes: An immunofluorescence and immunocolloidal gold-labeling study.
J. Cell Biol.
117:
337-345,
1992
17.
Fukushima, T.,
T. K. Waddell,
S. Grinstein,
G. G. Goss,
J. Orlowski,
and
G. P. Downey.
Na+/H+ exchange activity during phagocytosis in human neutrophils: role of Fcgamma receptors and tyrosine kinases.
J. Cell Biol.
132:
1037-1052,
1996
18.
Grinstein, S.,
M. Woodside,
T. K. Waddell,
G. P. Downey,
J. Orlowski,
J. Pouysségur,
D. C. P. Wong,
and
J. K. Foskett.
Focal localization of the NHE-1 isoform of the Na+/H+ antiport: assessment of effects on intracellular pH.
EMBO J.
12:
5209-5218,
1993[Medline].
19.
Harper, I. S.,
J. M. Bond,
E. Chacon,
J. M. Reece,
B. Herman,
and
J. J. Lemasters.
Inhibition of Na+/H+ exchange preserves viability, restores mechanical function, and prevents the pH paradox in reperfusion injury to rat neonatal myocytes.
Basic Res. Cardiol.
88:
430-442,
1993[Medline].
20.
Hosey, M. M.,
and
J. Z. Fields.
Quantitative and qualitative differences in muscarinic cholinergic receptors in embryonic and newborn chick hearts.
J. Biol. Chem.
256:
6395-6399,
1981
21.
Irisawa, H.,
and
R. Sato.
Intra- and extracellular actions of proton on the calcium current of isolated guinea pig ventricular cells.
Circ. Res.
59:
348-355,
1986
22.
Kaplan, S. H.,
H. Yang,
D. E. Gilliam,
J. Shen,
J. J. Lemasters,
and
W. E. Cascio.
Hypercapnic acidosis and dimethyl amiloride reduce reperfusion induced cell death in ischaemic ventricular myocardium.
Cardiovasc. Res.
29:
231-238,
1995[Medline].
23.
Karmazyn, M.
Amiloride enhances postischemic ventricular recovery: possible role of Na+/H+ exchange.
Am. J. Physiol.
255 (Heart Circ. Physiol. 24):
H608-H615,
1988
24.
Karmazyn, M.,
and
M. P. Moffat.
Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox.
Cardiovasc. Res.
27:
915-924,
1993
25.
Karmazyn, M.,
M. Ray,
and
J. V. Haist.
Comparative effects of Na+/H+ exchange inhibitors against cardiac injury produced by ischemia/reperfusion, hypoxia/reoxygenation, and the calcium paradox.
J. Cardiovasc. Pharmacol.
21:
172-178,
1993[Medline].
26.
Kentish, J. C.,
and
W. G. Nayler.
The influence of pH on the Ca2+-regulated ATPase of cardiac and white skeletal myofibrils.
J. Mol. Cell. Cardiol.
11:
611-617,
1979[Medline].
27.
Kieval, R. S.,
R. J. Bloch,
G. E. Lindenmayer,
A. Ambesi,
and
W. J. Lederer.
Immunofluorescence localization of the Na-Ca exchanger in heart cells.
Am. J. Physiol.
263 (Cell Physiol. 32):
C545-C550,
1992
28.
Kijima, Y.,
A. Saito,
T. L. Jetton,
M. A. Magnuson,
and
S. Fleischer.
Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes.
J. Biol. Chem.
268:
3499-3506,
1993
29.
Kleyman, T. R.,
and
E. J. Cragoe, Jr.
Amiloride and its analogs as tools in the study of ion transport.
J. Membr. Biol.
105:
1-21,
1988[Medline].
30.
Lagadic-Gossmann, D.,
K. J. Buckler,
and
R. D. Vaughan-Jones.
Role of bicarbonate in pH recovery from intracellular acidosis in the guinea-pig ventricular myocyte.
J. Physiol. (Lond.)
458:
361-384,
1992
31.
Lazdunski, M.,
C. Frelin,
and
P. Vigne.
The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH.
J. Mol. Cell. Cardiol.
17:
1029-1042,
1985[Medline].
32.
Liu, S.,
D. Piwnica-Worms,
and
M. Lieberman.
Intracellular pH regulation in cultured embryonic chick heart cells. Na+-dependent Cl
/HCO
3 exchange.
J. Gen. Physiol.
96:
1247-1269,
1990
33.
Liu, S.,
S. Taffet,
L. Stoner,
M. Delmar,
M. L. Vallano,
and
J. Jalife.
A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl tail length.
Biophys. J.
64:
1422-1433,
1993
34.
Mays, D. J.,
J. M. Foose,
L. H. Philipson,
and
M. M. Tamkun.
Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.
J. Clin. Invest.
96:
282-292,
1995.
35.
McDonough, A. A.,
Y. Zhang,
V. Shin,
and
J. S. Frank.
Subcellular distribution of the sodium pump isoform subunits in mammalian cardiac myocytes.
Am. J. Physiol.
270 (Cell Physiol. 39):
C1221-C1227,
1996
36.
Moffat, M. P.,
and
M. Karmazyn.
Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat and guinea-pig hearts.
J. Mol. Cell. Cardiol.
25:
959-971,
1993[Medline].
37.
Myers, M.
Diuretic therapy and ventricular arrhythmias in persons 65 years of age and older.
Am. J. Cardiol.
65:
599-603,
1990[Medline].
38.
Myers, M. L.,
and
M. Karmazyn.
Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694.
Ann. Thorac. Surg.
61:
1400-1406,
1996
39.
Myers, M. L.,
S. Mathur,
G.-H. Li,
and
M. Karmazyn.
Sodium-hydrogen exchange inhibitors improve postischaemic recovery of function in the perfused rabbit heart.
Cardiovasc. Res.
29:
209-214,
1995[Medline].
40.
Numata, M.,
K. Petrecca,
N. Lake,
and
J. Orlowski.
Identification of a mitochondrial Na+/H+ exchanger.
J. Biol. Chem.
273:
6951-6959,
1998
41.
Orchard, C. H.,
and
J. C. Kentish.
Effects of changes of pH on the contractile function of cardiac muscle.
Am. J. Physiol.
258 (Cell Physiol. 27):
C967-C981,
1990
42.
Orlowski, J.
Heterologous expression and functional properties of the amiloride high affinity (NHE-1) and low affinity (NHE-3) isoforms of the rat Na/H exchanger.
J. Biol. Chem.
268:
16369-16377,
1993
43.
Orlowski, J.,
and
S. Grinstein.
Na+/H+ exchangers in mammalian cells.
J. Biol. Chem.
272:
22373-22376,
1997
44.
Orlowski, J.,
R. A. Kandasamy,
and
G. E. Shull.
Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins.
J. Biol. Chem.
267:
9331-9339,
1992
45.
Page, E.,
and
L. P. McCallister.
Studies on the intercalated disk of rat left ventricular myocardial cells.
J. Ultrastruct. Res.
43:
388-411,
1973[Medline].
46.
Pierce, G. N.,
W. C. Cole,
K. Liu,
H. Massaeli,
T. G. Maddaford,
Y. J. Chen,
C. D. McPherson,
S. Jain,
and
D. Sontag.
Modulation of cardiac performance by amiloride and several selected derivatives of amiloride.
J. Pharmacol. Exp. Ther.
265:
1280-1291,
1993
47.
Pierce, G. N.,
and
H. Meng.
The role of sodium-proton exchange in ischemic/reperfusion injury in the heart.
Am. J. Cardiovasc. Pathol.
4:
91-102,
1992[Medline].
48.
Pierce, G. N.,
and
K. D. Philipson.
Na+-H+ exchange in cardiac sarcolemmal vesicles.
Biochim. Biophys. Acta
818:
109-116,
1985[Medline].
49.
Pucéat, M.,
I. Korichneva,
R. Cassoly,
and
G. Vassort.
Identification of band 3-like proteins and Cl
/HCO
3 exchange in isolated cardiomyocytes.
J. Biol. Chem.
270:
1315-1322,
1995
50.
Rotin, D.,
and
S. Grinstein.
Impaired cell volume regulation in Na+-H+ exchange-deficient mutants.
Am. J. Physiol.
257 (Cell Physiol. 26):
C1158-C1165,
1989
51.
Sato, R.,
A. Noma,
Y. Kurachi,
and
H. Irisawa.
Effects of intracellular acidification on membrane currents in ventricular cells of the guinea pig.
Circ. Res.
57:
553-561,
1985
52.
Scholz, W.,
and
U. Albus.
Na+/H+ exchange and its inhibition in cardiac ischemia and reperfusion.
Basic Res. Cardiol.
88:
443-455,
1993[Medline].
53.
Scholz, W.,
U. Albus,
L. Counillon,
H. Gögelein,
H.-J. Lang,
W. Linz,
A. Weichert,
and
B. A. Schölkens.
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion.
Cardiovasc. Res.
29:
260-268,
1995[Medline].
54.
Scholz, W.,
U. Albus,
H. J. Lang,
W. Linz,
P. A. Martorana,
H. C. Englert,
and
B. A. Schölkens.
Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia.
Br. J. Pharmacol.
109:
562-568,
1993[Medline].
55.
Spray, D. C.,
R. L. White,
F. Mazet,
and
M. V. Bennett.
Regulation of gap junctional conductance.
Am. J. Physiol.
248 (Heart Circ. Physiol. 17):
H753-H764,
1985.
56.
Sweadner, K. J.,
V. L. M. Herrera,
S. Amato,
A. Moellmann,
D. K. Gibbons,
and
K. R. H. Repke.
Immunologic identification of Na+, K+-ATPase isoforms in myocardium: isoform change in deoxycorticosterone acetate-salt hypertension.
Circ. Res.
74:
669-678,
1994
57.
Tani, M.,
K. Shinmura,
H. Hasegawa,
and
Y. Nakamura.
Effect of methylisobutyl amiloride on [Na+]i, reperfusion arrhythmias, and function in ischemic rat hearts.
J. Cardiovasc. Pharmacol.
27:
794-801,
1996[Medline].
58.
Tse, C.-M.,
S. Levine,
C. Yun,
S. Brant,
L. T. Counillon,
J. Pouysségur,
and
M. Donowitz.
Structure/function studies of the epithelial isoforms of the mammalian Na+/H+ exchanger gene family.
J. Membr. Biol.
135:
93-108,
1993[Medline].
59.
Tse, C.-M.,
A. I. Ma,
V. W. Yang,
A. J. M. Watson,
S. Levine,
M. H. Montrose,
J. Potter,
C. Sardet,
J. Pouysségur,
and
M. Donowitz.
Molecular cloning and expression of a cDNA encoding the rabbit ileal villus cell basolateral membrane Na+/H+ exchanger.
EMBO J.
10:
1957-1967,
1991[Medline].
60.
Vaughan-Jones, R. D.
Regulation of chloride in quiescent sheep-heart Purkinje fibres studied using intracellular chloride and pH-sensitive micro-electrodes.
J. Physiol. (Lond.)
295:
111-137,
1979
61.
Wakabayashi, S.,
M. Shigekawa,
and
J. Pouysségur.
Molecular physiology of vertebrate Na+/H+ exchangers.
Physiol. Rev.
77:
51-74,
1997
62.
Wallert, M. A.,
and
O. Fröhlich.
Na+-H+ exchange in isolated myocytes from adult rat heart.
Am. J. Physiol.
257 (Cell Physiol. 26):
C207-C213,
1989
63.
White, R. L.,
J. E. Doeller,
V. K. Verselis,
and
B. A. Wittenberg.
Gap junctional conductance between pairs of ventricular myocytes is modulated synergistically by H+ and Ca++.
J. Gen. Physiol.
95:
1061-1075,
1990
64.
Xu, L.,
G. Mann,
and
G. Meissner.
Regulation of cardiac Ca2+ release channel (ryanodine receptor) by Ca2+, H+, Mg2+, and adenine nucleotides under normal and simulated ischemic conditions.
Circ. Res.
79:
1100-1109,
1996
65.
Xue, Y. X.,
N. N. Aye,
and
K. Hashimoto.
Antiarrhythmic effects of HOE642, a novel Na+-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts.
Eur. J. Pharmacol.
317:
309-316,
1996[Medline].
66.
Yasutake, M.,
C. Ibuki,
D. J. Hearse,
and
M. Avkiran.
Na+/H+ exchange and reperfusion arrhythmias: Protection by intracoronary infusion of a novel inhibitor.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H2430-H2440,
1994
67.
Yu, F. H.,
G. E. Shull,
and
J. Orlowski.
Functional properties of the rat Na/H exchanger NHE-2 isoform expressed in Na/H exchanger-deficient Chinese hamster ovary cells.
J. Biol. Chem.
268:
25536-25541,
1993
68.
Zhang, J. F.,
and
S. A. Siegelbaum.
Effects of external protons on single cardiac sodium channels from guinea pig ventricular myocytes.
J. Gen. Physiol.
98:
1065-1083,
1991
This article has been cited by other articles:
![]() |
S. Stanbouly, L. A. Kirshenbaum, D. L. Jones, and M. Karmazyn Sodium Hydrogen Exchange 1 (NHE-1) Regulates Connexin 43 Expression in Cardiomyocytes via Reverse Mode Sodium Calcium Exchange and c-Jun NH2-Terminal Kinase-Dependent Pathways J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Saini and N. S. Dhalla Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchanger Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2790 - H2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Snabaitis, R. D'Mello, S. Dashnyam, and M. Avkiran A Novel Role for Protein Phosphatase 2A in Receptor-mediated Regulation of the Cardiac Sarcolemmal Na+/H+ Exchanger NHE1 J. Biol. Chem., July 21, 2006; 281(29): 20252 - 20262. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baumgartner, H. Patel, and D. L. Barber Na+/H+ exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes Am J Physiol Cell Physiol, October 1, 2004; 287(4): C844 - C850. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rohr Role of gap junctions in the propagation of the cardiac action potential Cardiovasc Res, May 1, 2004; 62(2): 309 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G Perez, M. C Villa-Abrille, E. A Aiello, R. A Dulce, H. E Cingolani, and M. C Camilion de Hurtado A low dose of angiotensin II increases inotropism through activation of reverse Na+/Ca2+ exchange by endothelin release Cardiovasc Res, December 1, 2003; 60(3): 589 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E Cingolani, N. G Perez, B. Pieske, D. von Lewinski, and M. C Camilion de Hurtado Stretch-elicited Na+/H+ exchanger activation: the autocrine/paracrine loop and its mechanical counterpart Cardiovasc Res, March 15, 2003; 57(4): 953 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Goel, A. Vecchini, V. Panagia, and G. N. Pierce Altered cardiac Na+/H+ exchange in phospholipase D-treated sarcolemmal vesicles Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1179 - H1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||